Novel Furan-2-yl-1 H-pyrazoles Possess Inhibitory Activity against α-Synuclein Aggregation

Philip Ryan, Mingming Xu, Kousar Jahan, Andrew K. Davey, Prasad V. Bharatam, Shailendra Anoopkumar-Dukie, Michael Kassiou, George D. Mellick, Santosh Rudrawar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


A series of novel furan-2-yl-1H-pyrazoles and their chemical precursors were synthesized and evaluated for their effectiveness at disrupting α-synuclein (α-syn) aggregation in vitro. The compounds were found to inhibit α-syn aggregation with efficacy comparable to the promising drug candidate anle138b. The results of this study indicate that compounds 8b, 8l, and 9f may qualify as secondary leads for the structure-activity relationship studies aimed to identify the suitable compounds for improving the modulatory activity targeted at α-syn self-assembly related to Parkinson's disease.

Original languageEnglish
Pages (from-to)2303-2315
Number of pages13
JournalACS Chemical Neuroscience
Issue number15
Publication statusPublished - 5 Aug 2020
Externally publishedYes


  • Molecular modeling studies
  • Neurodegenerative diseases
  • Parkinson's disease
  • aminopyrazole
  • anle138b
  • α-Synuclein aggregation


Dive into the research topics of 'Novel Furan-2-yl-1 H-pyrazoles Possess Inhibitory Activity against α-Synuclein Aggregation'. Together they form a unique fingerprint.

Cite this